IP Library Granted Patent US 7,364,592
Granted Patent B2
US 7,364,592 · App. 11/055,779 · Granted Apr 29, 2008

Biointerface membrane with macro-and micro-architecture

Assignee: DexCom, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,364,592
App. No.
11/055,779
Granted
Apr 29, 2008
Kind
B2
Abstract

Disclosed herein are biointerface membranes including a macro-architecture and a micro-architecture co-continuous with and bonded to and/or located within at least a portion of the macro-architecture. The macro- and micro-architectures work together to manage and manipulate the high-level tissue organization and the low-level cellular organization of the foreign body response in vivo, thereby increasing neovascularization close to a device-tissue interface, interfering with barrier cell layer formation, and providing good tissue anchoring, while reducing the effects of motion artifact, and disrupting the organization and/or contracture of the FBC. The biointerface membranes of the preferred embodiments can be utilized with implantable devices such as devices for the detection of analyte concentrations in a biological sample (for example, from a body), cell transplantation devices, drug delivery devices, electrical signal delivering or measuring devices, and/or combinations thereof.

Claims (13)

1. A biointerface membrane comprising a biostable membrane configured and arranged to be disposed on an in vivo implantable device, the biostable membrane comprising:

a macro-architecture defining a plurality of interconnected cavities that are greater than or equal to about 20 microns in a longest dimension; and

a micro-architecture located within at least some of the cavities of the macro-architecture, wherein the micro-architecture has a plurality of interconnected cavities that are less than or equal to about 20 microns in at least one dimension, and wherein the interconnected cavities of the micro-architecture are sized such that a plurality of the interconnected cavities of the micro-architecture fit within one interconnected cavity of the macro-architecture.

2. The biointerface membrane of claim 1 , wherein the membrane, when disposed on an implantable device, is adapted to support tissue ingrowth and to interfere with barrier cell layer formation.

3. The biointerface membrane of claim 1 , wherein the macro-architecture is formed from a homopolymer, copolymer, or terpolymer comprising a material selected from the group consisting of polyurethane, silicone, polyethylene-co-tetrafluoroethylene, polypropylene, polyvinylchloride, polyvinylidene fluoride, polybutylene terephthalate, polymethylmethacrylate, polyether ether ketone, cellulose ester, polysulfone, polyolefin, polyester, polycarbonate, polytetrafluoroethylene, and combinations thereof.

4. The biointerface membrane of claim 1 , wherein the micro-architecture comprises a homopolymer, copolymer, or terpolymer comprising a material selected from the group consisting of polyethylene-co-tetrafluoroethylene, polyurethane, silicone, polyethylene, polypropylene, polyvinylchloride, polyvinylidene fluoride, polyvinylidene difluoride, polybutylene terephthalate, polymethylmethacrylate, polyether ether ketone, cellulose ester, polysulfone, polyolefin, nylon, polyacrylonitrile, polyester, polycarbonate, polytetrafluoroethylene, expanded-polytetrafluoroethylene, and combinations thereof.

5. The biointerface membrane of claim 1 , wherein the macro-architecture comprises a silicone material having a structure that defines the cavities.

6. The biointerface membrane of claim 1 , wherein the micro-architecture comprises a silicone material.

7. The biointerface membrane of claim 1 , wherein the micro-architecture comprises a non-woven fibrous material.

8. The biointerface membrane of claim 7 , wherein the micro-architecture comprises expanded-polytetrafluoroethylene.

9. The biointerface membrane of claim 1 , wherein the micro-architecture is located throughout substantially all of the cavities of the macro-architecture.

10. The biointerface membrane of claim 1 , wherein the micro-architecture comprises elongated strands of material that are less than or equal to about 20 microns in a shortest dimension.

11. The biointerface membrane of claim 1 , wherein the plurality of interconnected cavities of the microarchitecture are at least about 0.6 microns in the at least one dimension.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2005
From: CARR-BRENDEL, VICTORIA; SIMPSON, PETER C.; BRAUKER, JAMES H.
To: DEXCOM, INC.
Reel/Frame 016461/0637 →
Continuity (2)
Provisional Application 6054472200 · Feb 12, 2004
Related Publication 20050251083A1 · Nov 10, 2005